You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,271,243


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,271,243
Title: Pharmaceutical composition
Abstract:Pharmaceutical composition which comprises an insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action, which shows a potent depressive effect on diabetic hyperglycemia and is useful for prophylaxis and treatment of diabetes.
Inventor(s): Ikeda; Hitoshi (Higashiosaka, JP), Sohda; Takashi (Takatsuki, JP), Odaka; Hiroyuki (Kobe, JP)
Assignee: Takeda Chemical Industries, Ltd. (Osaka, JP)
Application Number:09/722,597
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,271,243
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 6,271,243

Introduction

United States Patent 6,271,243, hereafter referred to as the '243 patent, is a significant example of how patent claims and subject matter eligibility are evaluated under U.S. patent law. This analysis will delve into the key aspects of the patent, including its claims, the patent landscape, and the relevant legal frameworks that govern its validity.

Patent Overview

The '243 patent, while not specifically detailed in the provided sources, can be analyzed through the lens of general patent law principles and recent updates in patent eligibility guidance.

Patent Claims and Scope

Definition of Patent Claims

Patent claims are essential for defining the scope of a patent's protection. They outline the specific elements of the invention that are protected by the patent[2].

Types of Patent Claims

In a typical patent application, there are independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[2].

Subject Matter Eligibility

Section 101 of the Patent Act

The '243 patent must comply with Section 101 of the Patent Act, which stipulates that patentable subject matter includes "any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof"[2][5].

Alice/Mayo Test

To determine patent eligibility, the Alice/Mayo test is often applied. This test involves two steps:

  1. Step One: Determine if the claims are directed to an ineligible concept, such as an abstract idea, a law of nature, or a natural phenomenon.
  2. Step Two: If the claims are directed to an ineligible concept, assess whether the claims have an inventive concept that transforms the nature of the claim into a patent-eligible application[5].

Practical Applications and Inventive Concepts

2024 USPTO Guidance Update

Recent updates from the USPTO emphasize the importance of integrating judicial exceptions into practical applications. For a claim to be patent-eligible, it must show that the abstract idea is applied in a way that provides concrete benefits or solves specific problems in the relevant field. This involves assessing whether additional elements in the claim impose meaningful limits on the exception, transforming it into patent-eligible subject matter[1].

Example from 2024 USPTO Guidance

For instance, if a claim involves receiving audio input, separating audio signals, and applying mathematical algorithms to enhance clarity, it may be considered an abstract idea without a practical application. However, if the separated audio components are used in a real-time speech recognition system to enhance voice command accuracy, this specifies a practical application that makes the claim patent-eligible[1].

The '243 Patent in Context

While specific details of the '243 patent are not provided, the principles outlined above are crucial for understanding its validity and scope.

Judicial Interpretations

Cases like Photocure ASA v. Kappos highlight the importance of precise interpretations of patent laws. For example, the Federal Circuit's interpretation of the term "product" in the context of patent term extensions can influence how claims are evaluated for eligibility[4].

Patent Landscape and Recent Developments

Impact of AI on Patent Eligibility

The increasing importance of AI technologies has raised concerns about patent eligibility. The USPTO has analyzed data to study the impact of the Alice decision on AI-related patent applications, suggesting that AI inventions may be at risk of patent ineligibility under current frameworks[5].

Stakeholder Views

Stakeholders have varied views on the current patent eligibility standards. Some argue that the Alice/Mayo framework has positively affected innovation by excluding abstract ideas, while others express concerns that it hampers innovation in emerging technologies like AI[5].

Metrics for Measuring Patent Scope

Research has shown that metrics such as independent claim length and count can be used to measure patent scope. These metrics have explanatory power for correlates of patent scope, such as patent maintenance payments, forward citations, and the breadth of patent classes[3].

Key Takeaways

  • Patent Claims: Define the scope of the patent's protection and must be carefully crafted to ensure patent eligibility.
  • Subject Matter Eligibility: Claims must comply with Section 101 of the Patent Act and pass the Alice/Mayo test to be considered patent-eligible.
  • Practical Applications: Integrating judicial exceptions into practical applications is crucial for transforming abstract ideas into patent-eligible subject matter.
  • Recent Developments: The USPTO's 2024 guidance update and judicial interpretations continue to shape the patent landscape, especially for emerging technologies like AI.

FAQs

Q: What is the significance of patent claims in a patent application? A: Patent claims define the scope of the patent's protection and are essential for determining what is protected by the patent.

Q: How does the Alice/Mayo test impact patent eligibility? A: The Alice/Mayo test determines if a claim is directed to an ineligible concept and if it has an inventive concept that transforms the claim into a patent-eligible application.

Q: What is the role of practical applications in patent eligibility? A: Practical applications are crucial for integrating judicial exceptions into meaningful limits that transform abstract ideas into patent-eligible subject matter.

Q: How has the 2024 USPTO guidance update affected AI-assisted inventions? A: The update clarifies that AI-assisted inventions are evaluated on equal footing with other technologies, focusing on the claimed invention itself rather than the method of invention development.

Q: What metrics can be used to measure patent scope? A: Metrics such as independent claim length and count can be used to measure patent scope and have explanatory power for various correlates of patent scope.

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz
  2. Patents | The Maryland People's Law Library
  3. Patent Claims and Patent Scope - SSRN
  4. Analyses of PhotoCure ASA v. Kappos, 603 F.3d 1372 - Casetext
  5. Patent-Eligible Subject Matter Reform: An Overview - CRS Reports

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,271,243

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 6,271,243

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 0861666 ⤷  Subscribe 91298 Luxembourg ⤷  Subscribe
European Patent Office 0861666 ⤷  Subscribe 300258 Netherlands ⤷  Subscribe
European Patent Office 0861666 ⤷  Subscribe SPC 038/2006 Ireland ⤷  Subscribe
European Patent Office 0861666 ⤷  Subscribe 07C0006 France ⤷  Subscribe
European Patent Office 0861666 ⤷  Subscribe CA 2007 00001 Denmark ⤷  Subscribe
European Patent Office 0861666 ⤷  Subscribe SPC/GB07/009 United Kingdom ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.